Zhengye Biotechnology Holding Ltd 6-K Filing
Ticker: ZYBT · Form: 6-K · Filed: Dec 12, 2025 · CIK: 1975641
| Field | Detail |
|---|---|
| Company | Zhengye Biotechnology Holding Ltd (ZYBT) |
| Form Type | 6-K |
| Filed Date | Dec 12, 2025 |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 6-K filing submitted by Zhengye Biotechnology Holding Ltd (ticker: ZYBT) to the SEC on Dec 12, 2025.
How long is this filing?
Zhengye Biotechnology Holding Ltd's 6-K filing is 1 pages with approximately 307 words. Estimated reading time is 1 minutes.
Where can I view the full 6-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 307 words · 1 min read · ~1 pages · Grade level 12.8 · Accepted 2025-12-12 16:10:35
Filing Documents
- ea0269164-6k_zhengye.htm (6-K) — 18KB
- ea026916401ex99-1_zhengye.htm (EX-99.1) — 728KB
- ea026916401ex99-2_zhengye.htm (EX-99.2) — 135KB
- 0001213900-25-121187.txt ( ) — 5947KB
- zybt-20250630.xsd (EX-101.SCH) — 53KB
- zybt-20250630_cal.xml (EX-101.CAL) — 62KB
- zybt-20250630_def.xml (EX-101.DEF) — 253KB
- zybt-20250630_lab.xml (EX-101.LAB) — 503KB
- zybt-20250630_pre.xml (EX-101.PRE) — 282KB
- ea0269164-6k_zhengye_htm.xml (XML) — 870KB
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 101. INS Inline XBRL Instance Document 101.SCH Inline XBRL Taxonomy Extension Schema Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Zhengye Biotechnology Holding Limited Date: December 12, 2025 By: /s/ Songlin Song Name: Songlin Song Title: Chief Executive Officer 2